Navigation Links
Anticoagulant in Medical News

New Anticoagulant Pill Works Well in Trial

Lower doses safe and effective after heart attack and stroke WEDNESDAY, June 17 (HealthDay News) -- The new anti-clotting pill rivaroxaban (Xarelto) lowers the risk of stroke, heart attack and death in patients who have had a heart attack or suffer from unstable angina, a new trial sho...

Afid Therapeutics Inc.'s New Anticoagulant Heparin Replacement Passes in Vivo Test

LANSING, Mich., Aug. 19 /PRNewswire/ -- Afid Therapeutics, Inc. announced today that it had completed successful in vitro and in vivo (whole animal) demonstrations of the efficacy of its new "traceless" anticoagulant, which is meant to replace heparin in many applications. The in vivo and some...

Different anticoagulant regimens yield equal results

NEW YORK, NY DECEMBER 4, 2007 Patients with acute coronary syndromes (ACS) receiving early invasive treatment including angiography and percutaneous coronary intervention (PCI) have comparable results at 1 year in terms of mortality and ischemic outcomes no matter which of three different anticoa...

'Artificial Golgi' may provide new insight into key cell structure

...nces that allow the body to function normally. The lab-on-a-chip device could lead to a faster and safer method for producing heparin, the widely used anticoagulant or blood thinner, the researchers note. Their study is scheduled for the Aug. 12 issue of the Journal of the American Chemical Society , a weekly pub...

The risk of developing deep vein thrombosis during a flight is often overestimated

...medications that can be used." These so-called "anticoagulant" medications reduce the blood's ability to clot. Heparins are among the most established anticoagulant medications. They are injected subcutaneously (under the skin). ...

Portola Pharmaceuticals Announces Several Scientific Presentations at International Society on Thrombosis and Haemostasis XII Congress

...ical development, and its oral Factor Xa inhibitor anticoagulant antidote in pre-clinical development, as well as a...xaban, an investigational oral Factor Xa inhibitor anticoagulant currently in Phase II clinical development. ...ulti-billion hospital, specialty, and chronic care anticoagulant and antiplatelet markets, respectively. Por...

Portola Pharmaceuticals to Host Conference Call at 11:00 a.m. Eastern Time Tomorrow to Discuss Betrixaban Partnership and Provide Corporate Update

...company's investigational oral Factor Xa inhibitor anticoagulant currently in Phase II clinical development for the...reted through the kidneys and is the only new oral anticoagulant currently being studied in patients with severe an...it has the potential to become the only novel oral anticoagulant available for patients with severe renal disease. ...

Instrumentation Laboratory Receives 510(k) Clearance From FDA for HemosIL(R) Liquid Heparin Assay

...patients who undergo orthopedic, cardiovascular and other surgeries. UFH and LMWH monitoring is critical in assessing and determining the appropriate anticoagulant activity in these patients. Due to the extensive number of such patients, the availability of a chromogenic anti-Xa assay, readily and always availab...

NORD to Honor Rare Disease Pioneers

...ive for seizures linked to Lennox-Gastaut syndrome, a severe form of childhood epilepsy GTC Biotherapeutics, Inc., for developing ATryn(R), an anticoagulant to prevent blood clots in people with a rare disease known as hereditary antithrombin (AT) deficiency Regeneron Pharmaceuticals, Inc., for dev...

Instrumentation Laboratory Wins Patent Infringement and Unfair Competition Trial Against Diagnostica Stago Relating to Reagents for Hemostasis Diagnostics

...ts are available for the management of antiphospholipid syndrome, coagulation factors, von Willebrand disease, fibrinolysis, and general screening and anticoagulant monitoring. Coupled with the ACL family of instruments, IL brings automation to the hemostasis lab. IL is dedicated to providing constant innovation t...
Anticoagulant in Medical Technology

Nuvelo Announces Positive Phase 1b Proof-of-Concept Data With Anticoagulant NU172

- Phase 2 development to begin in late 2008 or in early 2009 - SAN CARLOS, Calif., Aug. 14 /PRNewswire-FirstCall/ -- Nuvelo, Inc. (Nasdaq: NUVO ) today announced positive results from the Phase 1b proof-of-concept trial of NU172, demonstrating that the direct thrombin inhibitor rapidly p...

Diakron Licenses Anticoagulant Drug Candidate from Merck & Co., Inc.

Orchid Pharma partners with Diakron MORRIS PLAINS, N.J., Aug. 13 /PRNewswire/ -- Diakron Pharmaceuticals, Inc. announced today the signing of an exclusive license agreement for a novel investigational oral anticoagulant drug candidate discovered and developed through Phase I ...

Nuvelo Initiates Phase 1B Clinical Trial of Anticoagulant NU172

- Phase 2 trial expected to begin in late 2008 or early 2009 - SAN CARLOS, Calif., June 4 /PRNewswire-FirstCall/ -- Nuvelo, Inc. (Nasdaq: NUVO ) today announced that it has enrolled the first patient in a single-center, Phase 1b trial to determine the safety, tolerability and pharmacokin...

Genetics Determine Optimal Drug Dose of Common Anticoagulant

WASHINGTON, Aug. 21 /PRNewswire-USNewswire/ -- Genetic testing can be used to help personalize the therapeutic dosage of warfarin, a commonly-used anticoagulant, according to research published in the September 1, 2007, issue of Blood, the journal of the American Society of Hematology. This re...

Analysis of Edoxaban Phase II Data Provides Insight Into Reduced Bleeding Events Seen in Once-Daily Dosing

...ng events was examined using logistical regression. About Edoxaban Edoxaban, the molecule originally referred to as DU-176b, is an oral anticoagulant that directly inhibits Factor Xa, a clotting factor in the blood. Daiichi Sankyo is developing edoxaban as a potential new treatment for the preventi...

ThromboGenics and BioInvent Start Recruitment of Second 100 Patient Cohort in Phase II DVT Prophylaxis Study With TB-402

... ahead of schedule. TB-402 is a novel, long acting anticoagulant that is being developed for the prevention of deep...This would be an attractive option, as all current anticoagulant treatment options require daily treatment for up t...address the many drawbacks associated with current anticoagulant therapy. We remain confident in the large market p...

Commonwealth Fund Case Study Points to 'Continuous Innovation' at Group Health Cooperative

...r sickest/costliest patients to coach patients and reduce hospitalizations. Palliative care program with physician home visits for homebound patients. anticoagulant management service has reduced adverse drug events by 26 percent. Peer Review and Teamwork for High-Value Care ...

March 2009 Mayo Clinic Health Letter Highlights Knee Repair Surgery, Anxiety Disorder and Preventing Blood Clots

... deep vein thrombosis seeks to prevent the clot from becoming bigger and to reduce the risk of pulmonary embolism. Most people with DVT are prescribed anticoagulant medications to take for a minimum of three months. Mayo Clinic Health Letter is an eight-page monthly newsletter of reliable, accurate and prac...

For Old or Young Dialysis Patients, AV Fistulas Remain Pure Gold

...s' other medical conditions -- such as whether they had peripheral arterial disease (PAD) or diabetes, whether they were smokers and whether they used anticoagulant medications -- to see how this information would play in the big picture. Elderly patients were more likely to be affected by these conditions; howeve...

Alexion Reports Positive Results from AEGIS Registration Study of Soliris in Japanese Patients With PNH

...pharyngitis (a runny nose), back pain and nausea. Treatment with Soliris should not alter anticoagulant management because the effect of withdrawal of anticoagulant therapy during Soliris treatment has not been established. The U.S. product label for Soliris also includes a boxed warning: "Soliris increase...
Anticoagulant in Medical Products

Nonspecific Circulating Anticoagulant Inhibitor PTT

Description: ARUP Laboratories is a national reference laboratory and a worldwide leader in innovative laboratory research and development. ARUP offers an extensive test menu of highly complex and unique medical tests in clinical and anatomic pathology. Owned by the University of Utah, ARUP Laboratories' client...
Company:ARUP Laboratories

Nonspecific Circulating Anticoagulant Inhibitor PT

Description: ARUP Laboratories is a national reference laboratory and a worldwide leader in innovative laboratory research and development. ARUP offers an extensive test menu of highly complex and unique medical tests in clinical and anatomic pathology. Owned by the University of Utah, ARUP Laboratories' client...
Company:ARUP Laboratories

Lupus Anticoagulant Panel with Reflex to 1:1 Mixes & Confirmations

Description: ARUP Laboratories is a national reference laboratory and a worldwide leader in innovative laboratory research and development. ARUP offers an extensive test menu of highly complex and unique medical tests in clinical and anatomic pathology. Owned by the University of Utah, ARUP Laboratories' client...
Company:ARUP Laboratories

Coatest APC Resistance V Kit

Description:...pes. It also allows for analysis of plasma from patients on heparin or oral anticoagulant therapy. High discrimination between genotypes with 100% sensitivity for FV:Q506. Reduces need for PCR determination. Applicable to anticoagulant treated patients. Coatest APC Resistance V exclusively detects inherited AP...
Company:DiaPharma Group, Inc.

Coatest APC Resistance Kit

Description:...ased assay for the detection of the APC resistance phenotype, i.e. the poor anticoagulant response to activated protein C (APC). The test result (APC ratio) gives an estimation of the anticoagulant function in vivo and provides information on the thrombotic risk associated...
Company:DiaPharma Group, Inc.

Sonoclot Coagulation & Platelet Function Analyzer

Description:...e Sonoclot Analyzer is a versatile instrument for measuring coagulation and platelet function in whole blood or plasma. It is used worldwide to manage anticoagulant therapy, assess platelet function, control blood product usage, differentiate mechanical versus hemostatic bleeders, identify hypercoagulable and hepa...
Company:Sienco, Inc.

SURETRANS System

Description:...e surgeon connects the SURETRANS system to the closed wound drain(s). ACD-A anticoagulant may be added to the collection container through the injection port if desi...lter and blood transfer button; A patient drainage tube incorporating an anticoagulant injection port and a universal Y-connector for connection to the closed wou...
Company:Davol, Inc.

BD Vacutainer® Specialty Tubes - Acid Citrate Dextrose (ACD)

Features:... Whole blood tube with anticoagulant ACD Sol B ACD Sol A ...
Company:BD Diagnostic Systems

MCS® + 9000 System

Features:... Quick and easy system installation Simple operation, minimal training required Brief, automated priming of anticoagulant lines A compact design, ideal for mobile collection sites Instant upgrade possible through exchange of protocol cards...
Company:Haemonetics

ACT PLUS Automated Coagulation Timer System

Features:... BUILT-IN EFFICIENCY Immediate results mean anticoagulant dosages can be adjusted quickly. Dual-well testing provides the extra confidence that only duplicate results provide. Because less than 1 ml of ...
Company:Medtronic Inc.
Anticoagulant in Medical Dictionary

Vitamin K

...educes the rate of calcium loss from the bones in osteoporosis ... By preventing the blood clots that trigger heart attack and stroke, the anticoagulant ... Vitamin K is one of the key factors that allow our blood to clot. ... ...

Protein C

...C deficiency can be either passed down through families (inherited) or ... Protein C is a Vitamin K-dependent protease that functions as an anticoagulant ... This was expected given the role of Protein C in inhibiting factors Va and VIIIa. ... Activated Protein C is a serine protease which f...
Anticoagulant in Biological News

Genetics determine optimal drug dose of common anticoagulant

(WASHINGTON, August 21, 2007) Genetic testing can be used to help personalize the therapeutic dosage of warfarin, a commonly-used anticoagulant, according to research published in the September 1, 2007, issue of Blood , the journal of the American Society of Hematology. This result represents on...

For old or young dialysis patients, AV fistulas remain pure gold

...ients' other medical conditionssuch as whether they had peripheral arterial disease (PAD) or diabetes, whether they were smokers and whether they used anticoagulant medicationsto see how this information would play in the big picture. Elderly patients were more likely to be affected by these conditions; however, t...

UNC scientists teach enzyme to make synthetic heparin in more varieties

...sible for producing heparin, opening the door to a more effective synthetic anticoagulant as well as treatments for other conditions. Jian Liu, Ph.D., and collea...ed naturally by many creatures, including humans. As a drug, it is a common anticoagulant derived mainly from the intestinal lining of pigs. The manufactured form of...

Findings released from 1 of the largest percutaneous coronary intervention trials ever

... drug therapy cardiologists choose for their patients with heart attack. HORIZONS-AMI is the largest study ever to focus on the appropriate use of anticoagulant medications in patients experiencing STEMI and undergoing primary percutaneous coronary intervention (PCI). Only 7.2 percent of patients in the bivali...

Undergrad has sweet success with invention of artificial Golgi

... in the world. Heparin is formed naturally in the Golgi organelle in cells of the human body as well as in other animals like pigs. Heparin acts as an anticoagulant preventing blood clots, which makes it a good therapeutic for heart, stroke, and dialysis patients. The main source of heparin is currently the in...

Clumps of red and white blood cells may contribute to sickle cell disease

... disrupted the aggregates because blood collection tubes usually contain an anticoagulant that ties up calcium, which often plays a role in cell adhesion. She saw the aggregates only when she used an anticoagulant that doesnt remove calcium. Brittain and her colleagues plan further stu...

Safe and effective therapy discovered for patients with protein-losing enteropathy

...ate and prevents protein leakage in vitro. However, long-term therapy with anticoagulant heparin has severe side effects, including bleeding, thrombocytopenia and o...d in mice without causing bleeding. This compound exhibits greatly reduced anticoagulant activity, compared to unmodified heparin, which may mean that it can be use...

Does the victim affect snake venom composition?

...w therapeutic strategies to treat human diseases," says Prof Kini from the Department of Biological Sciences, National University of Singapore. "A new anticoagulant or a hypotensive toxin may help us develop new cardiovascular drugs to block unwanted clot formation or to lower the blood pressure." ...

Dogs keep dying: Many owners unaware of toxic dog food

...ing profile should assess the liver enzyme ALT to detect damage to the liver, serum cholesterol, total bilirubin concentration and the activity of the anticoagulant proteins antithrombin III (ATIII) and protein C. The coagulation protein tests, which have been adapted for dogs by Cornell researchers, have high val...

Genetic variation alters response to common anti-clotting drug

... Millions of people take the anticoagulant drug warfarin to prevent harmful clotting after a heart attack, stroke, or ...of genetic variability truly improves patient treatment with this frontline anticoagulant drug." ...
Anticoagulant in Biological Technology

ThromboGenics and BioInvent Start Phase II Trial of TB-402, a Novel, Long Acting Anticoagulant for Deep Vein Thrombosis (DVT) Prophylaxis

LEUVEN, Belgium and LUND, Sweden, February 23 /PRNewswire-FirstCall/ -- - Trial to Assess the Benefits of Partial Factor VIII Inhibition in Patients Undergoing Knee Replacement Surgery ThromboGenics NV (Euronext Brussels: THR) and co-development partner BioInvent International (O...

PCI Guideline Update Stresses Long-Term Anticoagulant Therapy After Treatment With Drug-Eluting Stents

WASHINGTON, Dec. 13 /PRNewswire/ -- Patients treated with drug-eluting stents must take a combination of aspirin and the clot-reducing drug clopidogrel for at least one year, and possibly longer, after stent implantation. This is a crucial message in a guideline update published online today i...

ThromboGenics and BioInvent Announce Successful Completion of Phase I Clinical Trial of the Anticoagulant TB-402

LEUVEN, Belgium and LUND, Sweden, September 7 /PRNewswire/ -- - Decision Taken to Advance Novel, Long-Acting Anticoagulant Into Phase II Clinical Development ThromboGenics NV (Euronext Brussels: THR), a biotechnology company focused on vascular disease, and co-development partner, BioInvent ...

Regado Biosciences Expands Medical Advisory Board

...thrombotic technology platform, including the REG1 anticoagulant system as it enters phase 2b with the RADAR trial....ized medicine. Regado's lead program, the anticoagulant system REG1, consists of two parenteral agents, th...can be used to completely or partially reverse the anticoagulant effect of RB006. Regado recently completed a phas...

Angiotech Pharmaceuticals announces FDA 510(k) clearance of the Option(TM) Inferior Vena Cava Filter

...llowing conditions: pulmonary thromboembolism when anticoagulant therapy is contraindicated, failure of anticoagulant therapy in thromboembolic diseases, emergency trea...ollowing massive PE, and chronic recurrent PE when anticoagulant therapy has failed or is contraindicated. The niti...

Regado Biosciences Establishes Medical Advisory Board

...r IXa inhibitor (RB006) and the second being its complementary active control agent (RB007). RB007 can be used to completely or partially reverse the anticoagulant effect of RB006. Regado recently completed a phase 2a study of REG1 in percutaneous coronary intervention (PCI) and is planning the initiation of a r...

ThromboGenics NV: Business Update

...ontinued to make considerable progress with our other key clinical and pre-clinical programs. We have begun a Phase II trial for our novel long-acting anticoagulant TB-402 and also received the first milestone from our strategic agreement with Roche for the novel anti-cancer agent TB-403. The development of Anti-V...

ARCA biopharma to Present at 27th Annual JPMorgan Healthcare Conference

...portunity, as well as Nuvelo's mid-stage pipeline asset, novel short-acting anticoagulant NU172. In September 2008, the FDA formally accepted for filing ARCA's New D...which has completed Phase 1 development for use as a potential short-acting anticoagulant during medical or surgical procedures; and NU206, a Wnt pathway modulator i...

Regado Biosciences To Present at the 27th Annual J.P. Morgan Healthcare Conference

...d highly selective Factor IXa inhibitor and the second being its complementary reversal agent which can be used to completely or selectively lower the anticoagulant effects. The REG1 System is currently in Phase 2 clinical testing. ...

Soliris(R) Reduced Measures of Thrombosis and Inflammation, and Decreased Indicators of Pulmonary Hypertension, in Studies of Patients with PNH

...pharyngitis (a runny nose), back pain and nausea. Treatment with Soliris should not alter anticoagulant management because the effect of withdrawal of anticoagulant therapy during Soliris treatment has not been established. The U.S. product label for Soliris also includes a boxed warning: "Soliris increase...
Anticoagulant in Biological Definition

Computed axial tomography

...ous contrast agents (contrast may resemble a bleed). CT generally does not exclude infarct in the acute stage, but is useful to exclude a bleed (so anticoagulant medication can be commenced safely). For detection of tumors , CT scanning with IV contrast is occasionally used but is less sensitive than mag...

Blood plasma

...ained from whole blood. To prevent clotting , an anticoagulant such as citrate or heparin is added to the bl...men immediately after it is obtained. (Usually the anticoagulant is already in the evacuated blood collection tube ... vacutainer or Vacuette) is usually used, as the anticoagulant effects of citrate is dependent upon concentration...
Anticoagulant in Biological Dictionary

Vena cava

...is, treatment, causes, patient stories, videos, forums, prevention, and prognosis. Inferior vena cava filters are often used as alternatives to anticoagulant ... Vena cava thrombosis occurred in 2.7% of the patients. ... ...

Inferior vena cava

.... The left-sided inferior vena cava drains into the left renal vein. ... Inferior vena cava filters are often used as alternatives to anticoagulant ... TABLE III. Summary of Reported Inferior Vena Cava Complications7,13,15,18,27 ,35, ... This fat projects into inferior vena cava (IV...
Other Tags
(Date:10/30/2014)... HealthDay Reporter WEDNESDAY, Oct. 29, 2014 ... of three West African nations ravaged by the disease -- ... Dr. Bruce Aylward, WHO,s assistant director general, said there,s been ... no increase in laboratory-confirmed cases. He said he was cautiously ... be making some progress, The New York Times ...
(Date:10/30/2014)... October 30, 2014 Global prebiotics market ... according to a new study by Grand View Research, ... demand for sugar and fat free products owing to ... demand for prebiotics over the forecast period. , View ... , Food & beverage was the largest application segment ...
(Date:10/30/2014)... (PRWEB) October 30, 2014 The annual ... (NAMS) came to a close on Saturday, October 18th, ... the Society’s inception in 1989. NAMS is North America’s ... quality of life of all women during midlife and ... With over 2,000 physicians and thought leaders from fields ...
(Date:10/30/2014)... who used stem cells to create miniature human stomachs ... new way to learn more about the development and ... pluripotent stem cells -- which can become any type ... functional miniature stomachs, to study infection by H. ... stomach cancer. The miniature stomachs offer many research ...
(Date:10/30/2014)... a low-carb, high-fat diet could help control epilepsy that ... A review of five studies found that a ... like bacon, eggs, heavy cream, butter, fish and green ... doesn,t improve with medication. "We need new treatments ... seizures are not stopped by medications," study co-author Dr. ...
Breaking Medicine News(10 mins):Health News:Ebola Outbreak in Liberia May Be Slowing: WHO 2Health News:Ebola Outbreak in Liberia May Be Slowing: WHO 3Health News:Prebiotics Market Is Expected To Grow At A CAGR Of 9.3% From 2014 To 2020: Grand View Research, Inc. 2Health News:Prebiotics Market Is Expected To Grow At A CAGR Of 9.3% From 2014 To 2020: Grand View Research, Inc. 3Health News:Prebiotics Market Is Expected To Grow At A CAGR Of 9.3% From 2014 To 2020: Grand View Research, Inc. 4Health News:Prebiotics Market Is Expected To Grow At A CAGR Of 9.3% From 2014 To 2020: Grand View Research, Inc. 5Health News:Highlights from The North American Menopause Society 25th Annual Meeting 2Health News:Highlights from The North American Menopause Society 25th Annual Meeting 3Health News:High-Fat, Low-Carb Diet May Help With Tough-to-Treat Epilepsy 2Health News:High-Fat, Low-Carb Diet May Help With Tough-to-Treat Epilepsy 3
(Date:10/28/2014)... Health (NIH) announced awards to expand the Office ... Center for Advancing Translational Sciences (ORDR-NCATS) collaborative Rare ... network, physician scientists at 22 consortia will work ... research and investigate new treatments for patients with ... $29 million in fiscal 2014 funding from NIH. ...
(Date:10/28/2014)... in a novel environment are linked to individual ... experimental study completed at the University of Eastern ... Institute. The study used novel, long-term observations of ... to analyse if behaviours predict the vulnerability to ... enriched hatchery rearing environments. Based on the ...
(Date:10/28/2014)... associated with a lower risk of developing ovarian cancer, ... Anglia (UEA). , Research published today reveals that ... subclasses of dietary flavonoids) significantly decrease their risk of ... death among women. , The research team studied ... and 55 for more than three decades. , ...
Breaking Biology News(10 mins):NIH's ORDR-NCATS RDCRN & NICHD awards U54 cooperative agreement for natural history study 2NIH's ORDR-NCATS RDCRN & NICHD awards U54 cooperative agreement for natural history study 3Fish 'personality' linked to vulnerability to angling 2Tea and citrus products could lower ovarian cancer risk, new UEA research finds 2
Other Contents